2 completed, 1 unknown. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Unknown 1 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
Follow Pituitary ACTH Hypersecretion: new trials by email Literature Review of Pituitary ACTH Hypersecretion trials Research Report on Pituitary ACTH Hypersecretion
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome atumelnant - Cushing Syndrome, Cushing Disease | Phase 1 / Phase 2 | Completed | Crinetics Pharmaceuticals Inc. | 19 | 2023-10-12 | 2026-10-14 |
| Vitamin D Metabolism in Patients With Endocrine Disorders Cholecalciferol 15000 UNT/ML Oral Solution - Pituitary ACTH Hypersecretion, Acromegaly | Phase 1 | Completed | Endocrinology Research Centre, Moscow | 261 | 2019-04-16 | 2022-08-11 |
| Preoperative Bexarotene Treatment for Cushing's Disease Bexarotene - Cushing's Disease | Phase 1 / Phase 2 | Unknown | University of Virginia | 6 | 2008-11-01 | 2011-05-30 |
ACTH Syndrome, Ectopic (1) · Acromegaly (1) · Cushing Syndrome (1) · Diabetes Mellitus, Type 1 (1) · Hyperparathyroidism, Primary (1) · Vitamin D Deficiency (1)
Brain Diseases (3) · Central Nervous System Diseases (3) · Endocrine System Diseases (3) · Hyperpituitarism (3) · Hypothalamic Diseases (3) · Nervous System Diseases (3) · Pituitary Diseases (3) · Adrenal Gland Diseases (1) · Adrenocortical Hyperfunction (1) · Autoimmune Diseases (1) · Avitaminosis (1) · Bone Diseases (1) · Bone Diseases, Endocrine (1) · Deficiency Diseases (1) · Diabetes Mellitus (1)
Bexarotene (1)
Crinetics Pharmaceuticals Inc. (1) · Endocrinology Research Centre, Moscow (1) · University of Virginia (1)
United States (2) · Russia (1)
Liudmila Rozhinskaya, MD, PhD (1) · Mary Lee Vance, MD (1)